J.T.Baker® Viral Inactivation Solution – Environmentally Safer Detergent for Virus Removal in Bioprocessing

J.T.Baker® Viral Inactivation Solution – Environmentally Safer Detergent for Virus Removal in Bioprocessing

Tuesday, October 28, 2025 5:00 PM to 9:00 PM · 4 hr. (Africa/Abidjan)

Information

Avantor’s J.T.Baker® Viral Inactivation Solution is an innovation in sustainable biomanufacturing. Designed to replace Triton™ X-100, an industry-standard detergent now restricted under EU REACH regulations due to its endocrine-disrupting and aquatic toxicity risks, this solution delivers high-performance viral inactivation while meeting today’s stringent environmental and regulatory standards.

The product is a ready-to-use, aqueous detergent formulation that inactivates lipid-enveloped viruses during the manufacture of biologics such as vaccines, monoclonal antibodies, plasma-derived therapies and gene therapies. It was engineered for biodegradability, low aquatic toxicity and ease of integration into upstream and downstream workflows, without requiring significant process changes.

J.T.Baker® Viral Inactivation Solution is REACH-compliant and does not require special authorization for use in the EU. The detergent is not classified as a Substance of Very High Concern (SVHC) and has been validated under OECD 301F biodegradability protocols. Safety testing confirms a low environmental footprint, with significantly reduced risks to aquatic organisms compared to conventional detergents.

Importantly, the solution achieves >6 log reduction values in model viruses such as XMuLV, HSV-1 and BVDV, demonstrating viral clearance performance that meets or exceeds current industry standards. It is supported by a comprehensive safety and regulatory package, including Permitted Daily Exposure (PDE) data and Certificate of Analysis, making it easier for manufacturers to adopt.

With the potential to eliminate up to 1,000,000 liters of toxic chemicals from manufacturing annually, this innovation offers a scalable, impactful sustainability solution for the global life sciences industry.

Avantor’s J.T.Baker® Viral Inactivation Solution empowers biopharmaceutical manufacturers to protect patients and the planet, without compromise.

Log in

See all the content and easy-to-use features by logging in or registering!